Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chubb
Moodys
Julphar
Baxter
US Army
US Department of Justice
McKesson
UBS

Generated: December 12, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062376

« Back to Dashboard

NDA 062376 describes ULTRACEF, which is a drug marketed by Bristol and Apothecon and is included in four NDAs. Additional details are available on the ULTRACEF profile page.

The generic ingredient in ULTRACEF is cefadroxil/cefadroxil hemihydrate. Twenty-seven suppliers are listed for this compound. Additional details are available on the cefadroxil/cefadroxil hemihydrate profile page.
Summary for 062376
Tradename:ULTRACEF
Applicant:Bristol
Ingredient:cefadroxil/cefadroxil hemihydrate
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FOR SUSPENSION;ORALStrengthEQ 125MG BASE/5ML
Approval Date:Mar 16, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:FOR SUSPENSION;ORALStrengthEQ 250MG BASE/5ML
Approval Date:Mar 16, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:FOR SUSPENSION;ORALStrengthEQ 500MG BASE/5ML
Approval Date:Mar 16, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
Dow
Johnson and Johnson
Fish and Richardson
Medtronic
Mallinckrodt
Moodys
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.